19 Oct 2023 Sequana Medical announces additional alfapump data supporting strong and durable clinical profile; PMA on track for year-end submission Member news
18 Oct 2023 Sequana Medical announces initial positive data from MOJAVE, a US Phase 1/2a study of DSR® 2.0 for treatment of heart failure through breaking vicious cycle of cardiorenal syndrome Member news
09 Oct 2023 SwiftPharma launches ODIN.AI: A groundbreaking AI-augmented antibody discovery platform Member news
06 Oct 2023 Agomab receives FDA Fast Track Designation for AGMB-129 in Fibrostenosing Crohn’s Disease and starts STENOVA Phase 2a clinical trial Member news
04 Oct 2023 Rejuvenate Biomed announces positive results from Phase 1b clinical trial with RJx-01 in sarcopenia Member news
27 Sep 2023 Mithra Announces Presentation of Positive Data on Estetrol (E4) Native Estrogen Member news
27 Sep 2023 SwiftPharma and Medace sign strategic collaboration agreement for biomanufacturing and purification of promising medicinal proteins. Member news
15 Sep 2023 argenx announces positive CHMP opinion for subcutaneous efgartigimod for generalized myasthenia gravis Member news
08 Sep 2023 SwiftPharma and the Population Council Pursue Agreement to Manufacture Griffithsin Needed for the Development of a Fast-Dissolving Insert for Protection Against HIV Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
